2010 Scrip 100 - Are the BRICs all they're cracked up to be?
This article was originally published in Scrip
Executive Summary
Despite the notable shift in the geographical focus of clinical trials, studies conducted in the BRIC and other fast-growing economies are still dwarfed by programmes done in the US. Moreover, structural problems in the emerging markets remain unresolved. Dr Peter Charlish and Stefan Fritsch mull over these and other outsourcing trends with some of the sector's leading lights.